NewAmsterdam Pharma Company NV’s filing revealed that its Affiliate NAP PoolCo B.V. acquired Company’s shares for reported $30.9 million on Jul 14 ’25. In the deal valued at $21.56 per share,1,433,193 shares were bought.
Then, Topper James N bought 2,520 shares, generating $46,454 in total proceeds. Upon buying the shares at $18.43, the Director now owns 3,024,873 shares.
Before that, Topper James N bought 1,260 shares. NewAmsterdam Pharma Company NV shares valued at $23,012 were divested by the Director at a price of $18.26 per share. As a result of the transaction, Topper James N now holds 3,026,133 shares, worth roughly $63.61 million.
Citigroup initiated its NewAmsterdam Pharma Company NV [NAMS] rating to a Buy in a research note published on June 17, 2025; the price target was $42. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering NAMS with “an Overweight” recommendation on June 04, 2025. H.C. Wainwright started covering the stock on December 30, 2024. It rated NAMS as “a Buy”.
Price Performance Review of NAMS
On Tuesday, NewAmsterdam Pharma Company NV [NASDAQ:NAMS] saw its stock fall -5.19% to $21.02. Over the last five days, the stock has gained 5.00%. NewAmsterdam Pharma Company NV shares have risen nearly 0.14% since the year began. Nevertheless, the stocks have fallen -18.21% over the past one year. While a 52-week high of $27.29 was reached on 01/02/25, a 52-week low of $14.06 was recorded on 04/07/25.
Levels Of Support And Resistance For NAMS Stock
The 24-hour chart illustrates a support level at 20.49, which if violated will result in even more drops to 19.96. On the upside, there is a resistance level at 22.06. A further resistance level may holdings at 23.11.
How much short interest is there in NewAmsterdam Pharma Company NV?
A steep rise in short interest was recorded in NewAmsterdam Pharma Company NV stocks on 2025-06-13, growing by 0.27 million shares to a total of 6.97 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 6.7 million shares. There was a rise of 3.9%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 15, 2024 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating .
